RBMX and cancer: MUC16 mutations also co-occurred with RBMX, CDC27, and AHNAK2. MutSigCV analysis identified TP53, CDC27, PIK3CA, CDH1, STK39, and FOXO3 as possible cancer drivers in grade 3 tumors (Additional file 1: Table S6).